o.silva
Submits third-party assay reports on material purchased directly. Based in Braga.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
7
n=7
Annotations
0
n=0
Median purity submitted
98.72%
n=7
Suppliers covered
7
n=7
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041951 | SS-31 (Elamipretide) | TFC | TFC-2607-R4363 | Medutest | 2026-Q3 | 99.56 | 5.16 | — | Buyer-sourced | 0 | PASS |
| AX-2025-020467 | BPC-157 | KP | KP-2511-M5346 | Janoshik | 2025-Q4 | 98.26 | 5.30 | 101.5 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020162 | Liraglutide | GGPeps | GGPE-2505-W9629 | Janoshik | 2025-Q4 | 98.72 | 7.05 | 102.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019412 | TB-500 | Homopeptide | HOMO-2410-E8462 | Janoshik | 2025-Q1 | 99.93 | 4.99 | — | Supplier-supplied | 0 | PASS |
| AX-2025-018829 | CJC-1295 (no DAC) | QSC | QSC-2410-L8549 | Janoshik | 2024-Q4 | 98.65 | 6.41 | 100.9 | Supplier-supplied | 2 | MARGINAL |
| AX-2024-004841 | BPC-157 | HJ | HJ-2407-D4137 | Janoshik | 2024-Q4 | 99.93 | 7.69 | — | Supplier-supplied | 0 | PASS |
| AX-2024-005079 | Semaglutide | MKM | MKM-2403-C3618 | Janoshik | 2024-Q2 | 98.36 | 5.80 | 106.2 | Supplier-supplied | 1 | MARGINAL |